On November 21st the Guerriero lab attended the 2022 Ludwig Retreat. It was amazing to connect with everyone and discuss all the great work being done at the Ludwig Center at Harvard Medical School. For more information on the Ludwig…
The lab had a great time at SITC 2022 here in Boston. After great talks at the conference, a chance to discuss with some great food.
On October 4th, the Guerriero Lab turned 2 years old! We are so grateful for all the lab has accomplished so far! We are excited to see what our future research brings.
Congratulations to Dr. Guerriero on receiving funding from the Concern Foundation. The lab is grateful for the support and is excited to continue researching new ways to improve breast cancer therapy. Link to funding: https://www.concernfoundation.org/researchers-we-fund
The Guerriero lab would like to welcome Kelly Zheng to the team! Kelly has also been jointly appoint to the Laboratory of Systems Pharmacology where she will be working on projects involving CyCIF.
Focus on suppressive macrophages may boost effects of PARP inhibitors.
Mehta et al. Nature Cancer, 2021 BWH Press Release
Modulating the immune system as an anti-cancer strategy has shown great promise in some types of cancer, however there has been limited responses in breast cancer. While the main focus of immunotherapy has been on the adaptive immune system, namely…
